MATTESINI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.215
EU - Europa 1.106
AS - Asia 326
AF - Africa 23
SA - Sud America 4
OC - Oceania 1
Totale 3.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.208
RU - Federazione Russa 643
IE - Irlanda 150
SE - Svezia 131
SG - Singapore 109
CN - Cina 80
IT - Italia 70
HK - Hong Kong 59
PL - Polonia 52
IN - India 32
CI - Costa d'Avorio 18
ES - Italia 18
VN - Vietnam 18
JO - Giordania 14
DE - Germania 12
UA - Ucraina 12
CA - Canada 7
IR - Iran 7
FI - Finlandia 6
GB - Regno Unito 5
KE - Kenya 4
JP - Giappone 3
AR - Argentina 2
BR - Brasile 2
FR - Francia 2
NL - Olanda 2
PK - Pakistan 2
RS - Serbia 2
GR - Grecia 1
KR - Corea 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 3.675
Salva come PNG Salva come JPEG
Città #
Santa Clara 542
Fairfield 313
Seattle 144
Dublin 138
Woodbridge 136
Houston 123
Ashburn 116
Cambridge 112
Wilmington 89
Singapore 83
Medford 58
Lawrence 55
Warsaw 52
Princeton 46
Buffalo 44
Moscow 38
Chandler 34
Beijing 32
Mumbai 32
Hong Kong 26
Ann Arbor 24
Altamura 22
Abidjan 18
Barcelona 18
Dong Ket 16
San Diego 16
Shanghai 15
Florence 13
Norwalk 12
Kent 11
Falls Church 10
Hillsboro 8
New York 7
Tehran 6
Andover 5
Boardman 5
Nairobi 4
Redmond 4
Toronto 4
Yubileyny 4
Espoo 3
Guangzhou 3
Helsinki 3
Laurel 3
Lucera 3
Montreal 3
Rome 3
Abbiategrasso 2
Belgrade 2
Boston 2
Buenos Aires 2
Fuzhou 2
London 2
Milan 2
Munich 2
Mykolayiv 2
Perugia 2
Recife 2
Redwood City 2
Reston 2
Shenzhen 2
Tyumen 2
Zhuhai 2
Amstelveen 1
Ardabil 1
Auckland 1
Bologna 1
Casoria 1
Cedar Knolls 1
Foshan 1
Genoa 1
Haining 1
Hounslow 1
Los Angeles 1
Menlo Park 1
Ponte San Pietro 1
Prato 1
Prescot 1
Sesto San Giovanni 1
Thessaloniki 1
Torino 1
University Center 1
Wuhan 1
Wuhu 1
Ysselsteyn 1
Totale 2.510
Salva come PNG Salva come JPEG
Nome #
The DESolve novolimus bioresorbable Scaffold: From bench to bedside 143
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 110
A Brief History of Coronary Artery Stents 105
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 104
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 103
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 102
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? 100
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 92
Absorb vs. DESolve: An optical coherence tomography comparison of acute mechanical performances 90
Calcium: A predictor of interventional treatment failure across all fields of cardiovascular medicine 90
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 88
A simple step-by-step approach for proficient utilization of the EchoNavigator technology for left atrial appendage occlusion 88
Percutaneous Trans-septal Mitral Valve-in-Ring Implantation Using a Transcatheter Balloon-Expandable Transcatheter Heart Valve With Elective Intra-Procedural Artero-Venous ECMO in a Patient With Severely Reduced Left Ventricular Ejection Fraction 88
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 87
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 85
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 84
Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty 83
Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds 82
Impact of stent strut design in metallic stents and biodegradable scaffolds 82
An amber signal lights up before the red: Do not dismiss it 81
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 81
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 77
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 76
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 76
Patent foramen ovale closure: how to choose the right device for the right patient 74
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry 74
Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents 74
Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience 72
TAVR in patients with hip fracture and severe aortic stenosis: how and when? 72
Will Optical Coherence Tomography Become the Standard Imaging Tool for Percutaneous Coronary Intervention Guidance? 71
Very high-pressure dilatation for undilatable coronary lesions: Indications and results with a new dedicated balloon 71
Il trattamento delle occlusioni coronariche croniche: Stato dell'arte 71
The Forgotten Art of Balloon Angioplasty 70
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage 70
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation 69
[Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit] 67
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry 66
ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance 62
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 60
Riserva frazionale di flusso: una breve guida pratica all'utilizzo per l'interventista e il punto di vista del cardiologo clinico 59
EuroCTO Club 2018 meeting: "Experts Live" in Toulouse 57
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 55
Bioresorbable Scaffold Thrombosis: Why BRS Size Matters 54
Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis? 52
No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization 45
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study 44
Urgent coronary angiography in out-of-hospital cardiac arrest: a retrospective single centre investigation 42
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital 42
Inducing persistent flow disturbances accelerates atherogenesis and promotes thin cap fibroatheroma development in D374Y-PCSK9 hypercholesterolemic minipigs 41
Totale 3.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020381 0 0 0 0 58 63 65 60 60 35 27 13
2020/2021345 16 22 12 38 53 49 10 24 36 38 19 28
2021/2022334 5 14 19 25 11 20 9 25 16 11 58 121
2022/2023507 78 114 42 16 2 92 74 21 44 2 18 4
2023/2024247 11 30 51 22 17 16 8 37 10 17 19 9
2024/20251.501 102 276 142 350 631 0 0 0 0 0 0 0
Totale 3.731